Amicus Therapeutics Crashed 54%, But Chardan Is Buying By: Benzinga via Benzinga October 05, 2015 at 09:40 AM EDT Amicus Therapeutics, Inc (NASDAQ: FOLD) shares have plunged 54 percent in the last three months, despite crossing the $18 mark on ... Read More >> Related Stocks: Amicus Therapeutics